Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Sprinzl

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|June 28, 2011
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJörn M Schattenberg, Tim Zimmermann, Marcus Wörns, et al.
World Journal of Gastroenterology|January 20, 2009
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patientsMarkus Moehler, Martin-F Sprinzl, Murad Abdelfattah, et al.
European Journal of Internal Medicine|August 23, 2018
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathyChristian Labenz, Larissa Beul, Gerrit Toenges, et al.
Plos One|August 10, 2017
Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical useKarin Wisskirchen, Kai Metzger, Sophia Schreiber, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2015
Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvirSebastian Bernuth, Eray Yagmur, Detlef Schuppan, et al.
Hamostaseologie|July 30, 2021
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case ReportMarie-Kristin Schwaegermann, Lukas Hobohm, Johanna Rausch, et al.
Plos Pathogens|February 2, 2022
Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
Plos Pathogens|December 3, 2021
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
United European Gastroenterology Journal|November 23, 2020
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|June 28, 2011
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJörn M Schattenberg, Tim Zimmermann, Marcus Wörns, et al.
World Journal of Gastroenterology|January 20, 2009
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patientsMarkus Moehler, Martin-F Sprinzl, Murad Abdelfattah, et al.
European Journal of Internal Medicine|August 23, 2018
Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathyChristian Labenz, Larissa Beul, Gerrit Toenges, et al.
Plos One|August 10, 2017
Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical useKarin Wisskirchen, Kai Metzger, Sophia Schreiber, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2015
Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvirSebastian Bernuth, Eray Yagmur, Detlef Schuppan, et al.
Hamostaseologie|July 30, 2021
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case ReportMarie-Kristin Schwaegermann, Lukas Hobohm, Johanna Rausch, et al.
Plos Pathogens|February 2, 2022
Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
Plos Pathogens|December 3, 2021
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteinsMarc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
United European Gastroenterology Journal|November 23, 2020
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
Pageof 5